InvestorsHub Logo

runncoach

04/13/18 4:19 PM

#6129 RE: Cyosol #6128

I'm not sure that's true.

Plus last trial only cost 9 million and at this point no reason to believe there will be 150 patient study. I hope more but may not even be 100. I can almost guarantee we won't spend as much this year on a clinical trial as we paid WCT last year. Plus most WCT money was back ended.

Like I say doesn't matter to me either way but I could very well see them waiting til next spring to raise some money.